Compounds > phenyl acetate
Page last updated: 2024-08-23

phenyl acetate and Cranial Nerve IV Diseases

phenyl acetate has been researched along with Cranial Nerve IV Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burdon, M; Deokule, S; Matthews, T1
Kosmorsky, GS; Leigh, RJ; Tomsak, RL1

Trials

1 trial(s) available for phenyl acetate and Cranial Nerve IV Diseases

ArticleYear
Gabapentin attenuates superior oblique myokymia.
    American journal of ophthalmology, 2002, Volume: 133, Issue:5

    Topics: Acetates; Administration, Oral; Adult; Amines; Cyclohexanecarboxylic Acids; Diplopia; Excitatory Amino Acid Antagonists; Eye Movements; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Treatment Outcome; Trochlear Nerve Diseases

2002

Other Studies

1 other study(ies) available for phenyl acetate and Cranial Nerve IV Diseases

ArticleYear
Superior oblique myokymia improved with gabapentin.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2004, Volume: 24, Issue:1

    Topics: Acetates; Administration, Oral; Aged; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Trochlear Nerve Diseases

2004